Transplant Oncology: Cancers, Immunosuppression, and Novel Therapies
Received Date: Dec 02, 2025 / Published Date: Dec 30, 2025
Abstract
Transplant oncology deals with the elevated risk of malignancies post-transplantation and managing pre-existing cancers. It
explores viral oncogenesis, the impact of immunosuppression, and specific cancers like HCC and skin cancer. Strategies for risk
stratification, surveillance, and novel therapies are discussed, along with molecular mechanisms. Long-term surveillance for HSCT
survivors is crucial
Citation: Alvarez DR (2025) Transplant Oncology: Cancers, Immunosuppression, and Novel Therapies. troa 10: 330.
Copyright: 漏 2025 Dr. Ricardo Alvarez This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permitsunrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 194
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 134
- PDF downloads: 60
